BioSpace News Archive

Aruvant announced that management will participate in the 2022 BIO CEO & Investor conference taking place at the Marriott Marquis in New York City from February 14 to 15 and virtually through February 17, 2022.

Movano Inc. announced that it will be participating in the virtual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 15 – Thursday, February 17, 2022.

Miach Orthopaedics, Inc. announced Miach founder Dr. Martha Murray’s research on the development of the company’s BEAR® Implant was selected for the 2022 Orthopaedic Research and Education Foundation Clinical Research Award.

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced several organizational changes and a new operating model to support the long-term growth strategy of the Life Science business sector and to better serve the evolving needs of its global customers.

Clarity Pharmaceuticals is pleased to announce that it has received a confirmation from the US Food and Drug Administration (FDA) that the diagnostic 64 Cu SAR-bisPSMA trial (COBRA) may proceed.

Simcere is thrilled to announce Bijoyesh Mookerjee, M.D., as our Chief Medical Officer, Oncology, of Simcere Pharmaceutical Group.

Myovant Sciences, a healthcare company focused on redefining care for women and for men, announced that David Marek, Chief Executive Officer of Myovant Sciences, Inc., and other members of the Myovant executive team will participate in a fireside chat at the following investor conferences:

Check-Cap Ltd. today announced that the Company has received approval from the U.S. Food and Drug Administration (FDA) for its amended Investigational Device Exemption (IDE) application, enabling initiation of the U.S. pivotal study.

Revelation Biosciences Inc. announced that its Chief Executive Officer James Rolke will present a corporate overview in-person at 10:45 a.m. EST on February 14, 2022 at the BIO CEO & Investor Conference, which is being held at the New York Marriott Marquis in New York City, NY on February 14-17.